The disclosure relates generally to methods and arrangements relating to medical devices. More specifically, the disclosure relates to the systems and methods used in a cardiac arrest alert system and in a preferred embodiment to a cardiac arrest alert system with a subcutaneous sensor system intended to identify the actual or imminent onset of a Sudden Cardiac Arrest (SCA) especially where this may be used to alert the carrier of a nearby portable Automated External Defibrillator (AED), EMS, companions or bystanders in order to more rapidly save the life of the Sudden Cardiac Arrest victim.
A primary task of the heart is to pump oxygenated, nutrient-rich blood throughout the body. Electrical impulses generated by a portion of the heart regulate the pumping cycle. When the electrical impulses follow a regular and consistent pattern, the heart functions normally and the pumping of blood is optimized. When the electrical impulses of the heart are disrupted (i.e., cardiac arrhythmia), this pattern of electrical impulses becomes chaotic or overly rapid, and a Sudden Cardiac Arrest may take place, which inhibits the circulation of blood. As a result, the brain and other critical organs are deprived of nutrients and oxygen. A person experiencing Sudden Cardiac Arrest may suddenly lose consciousness and die shortly thereafter if left untreated.
The most successful therapy for Sudden Cardiac Arrest is prompt and appropriate defibrillation. A defibrillator uses electrical shocks to restore the proper functioning of the heart.
A crucial component of the success or failure of defibrillation, however, is time. Ideally, a victim should be defibrillated immediately upon suffering a Sudden Cardiac Arrest, as the victim's chances of survival dwindle rapidly for every minute without treatment.
One of the biggest challenges with saving victims of a Sudden Cardiac Arrest is that they are often not near an external defibrillator when it happens and that once EMS are actually notified it then takes the medical professionals too long to arrive at the scene with a defibrillator to be able to successfully revive the victim. In many cases the SCA is not even witnessed when the person experiences the Sudden Cardiac Arrest and this means that they are not found for some period of time and then, once they are found, it is already too late to successfully resuscitate them.
There are a wide variety of defibrillators. For example, Implantable Cardioverter-Defibrillators (ICD) involve surgically implanting wire coils and a generator device within a person. ICDs are typically for people at high risk for a cardiac arrhythmia. When a cardiac arrhythmia is detected, a current is automatically passed through the heart of the user with little or no intervention by a third party.
Another, more common type of defibrillator is the automated external defibrillator (AED). Rather than being implanted, the AED is an external device used by a third party to resuscitate a person who has suffered from sudden cardiac arrest.
A typical protocol for using the AED 100 is as follows. Initially, the person who has suffered from sudden cardiac arrest is placed on the floor. Clothing is removed to reveal the person's chest 108. The pads 104 are applied to appropriate locations on the chest 108, as illustrated in
Although existing technologies work well, there are continuing efforts to improve the effectiveness, safety and usability of automatic external defibrillators. Accordingly, efforts have been made to improve the availability of automated external defibrillators (AED), so that they are more likely to be in the vicinity of Sudden Cardiac Arrest victims. Advances in medical technology have reduced the cost and size of automated external defibrillators (AED). Some modern AEDs approximate the size of a laptop computer or backpack. Even small devices may typically weigh 4-10 pounds or more. Accordingly, they are increasingly found mounted on the walls in public facilities (e.g., airports, schools, gyms, etc.) and, more rarely, residences. Unfortunately, the average survival rates for an out-of-hospital Sudden Cardiac Arrest remain abysmally low (around 8.3%).
Yet such wall-mounted solutions, while efficacious, are still less than ideal for most real world situations. Assume, for example, that a person suffers from a cardiac arrest in an airport in which multiple AEDs have been distributed. The victim's companion, or a bystander, would nevertheless have to locate and run towards the nearest AED, pull the device out of the locked cabinet on the wall, and then return to the collapsed victim before they can even begin to render assistance. During that time, precious minutes may have passed. According to some estimates, the chance of surviving a sudden cardiac arrest is 90% if the victim is defibrillated within one minute, but declines by 10% for every minute thereafter.
An additional challenge is that a sudden cardiac arrest may take place anywhere. People often spend time away from public facilities and their homes. For example, a sudden cardiac arrest could strike someone while biking in the hills, skiing on the mountains, strolling along the beach, or jogging on a dirt trail. Ideally, an improved AED design would be compact, light, and resistant to the elements and easily attached or detached from one's body. The typical AED design illustrated in
New and improved designs are allowing AEDs to become ultra-portable and hence to able to be easily carried by an at-risk person as they go about all of their daily activities and thus are able to be close at hand when a sudden cardiac arrest strikes outside of a hospital environment or a high traffic public area with a Public Access Defibrillator. There are also improvements being made in the area of device usability and ease of operation for untrained bystanders. As noted above, every minute of delay or distraction can substantially decrease the victim's probability of survival.
Another type of defibrillator is the Wearable Cardioverter Defibrillator (WCD). Rather than a device being implanted into a person at-risk from Sudden Cardiac Arrest, or being used by a bystander once a person has already collapsed from experiencing a Sudden Cardiac Arrest, the WCD is an external device worn by an at-risk person which continuously monitors their heart rhythm to identify the occurrence of an arrhythmia, to then correctly identify the type of arrhythmia involved and then to automatically apply the therapeutic action required for the type of arrhythmia identified, whether this be cardioversion or defibrillation. These devices are most frequently used for patients who have been identified as potentially requiring an ICD and to effectively protect them during the two to six month medical evaluation period before a final decision is made and they are officially cleared for, or denied, an ICD.
While these devices are worn by the patient and monitor them almost 24 hours per day, they are only worn by patients that have been diagnosed as needing an ICD or its equivalent. This constant monitoring is not available to other types of patient, and almost 50% of all Sudden Cardiac Arrests happen to people that have had no prior diagnosis of cardiac problems.
There are multiple types of cardiac monitoring technologies on the market today. These vary from traditional holters and event recorders (including the latest event recorder patches and subcutaneous loop recorders), to mobile cardiac monitoring devices and to close-to-real-time ambulatory telemetry devices. All of these are intended to provide accurate data which can aid in the accurate medical diagnoses of patients under the scrutiny/care of medical professionals and they are not intended to provide any sort of emergency services. The medical staff at a central monitoring center may, upon witnessing a suspected syncopy event in the ECG strip of an ambulatory patient being monitored, then call the patient to find out if they are conscious and if not then they may escalate the call to the patient's family, doctor and even EMS—but this is not intended to identify lethal arrhythmias such as Ventricular Fibrillation and Ventricular Tachycardia, or any other life threatening cardiac rhythm that requires defibrillation, and to assist in getting a life saving defibrillator to the victim as fast as possible.
Cardiac monitoring devices are intended for the detection of non-lethal arrhythmias to aid in physician diagnoses. They are found in a range of sizes, embody a range of technologies and a range of approaches (from recording the ECG for later analysis which is then provided in a report to the clinician, to almost-real-time telemetry systems). These do not constitute an automated cardiac arrest alert system, as they are not intended to detect a lethal arrhythmia and trigger an alarm or alert.
ICDs and WCDs are complex and expensive devices that both automatically detect and automatically treat the lethal arrhythmias of Ventricular Fibrillation and Ventricular Tachycardia, but only for patients who have already been diagnosed as being very sick and who are known to be at a high risk of imminent cardiac arrest. These are not considered to be clinically appropriate for prescription to patients that do not (yet) meet the strict definitions for being at high risk, nor are they approved for reimbursement by the insurers for such patients.
WCDs currently experience the challenge of reduced accuracy in identifying lethal arrhythmias, as the ECG signals that are obtained from skin mounted ECG sensors are fainter, noisier and subject to much more interference from patient motion-triggered artifacts, and as such result in a higher level of false positives. For this reason WCDs currently incorporate a patient-controlled override button, allowing the patient the ability to prevent the WCD from shocking them inappropriately in the event of a false positive.
One of the reasons that the national annual mortality burden from SCA remains so high is that there is no system for immediate notification that a patient has experienced an Out Of Hospital Cardiac Arrest. Such a system would enable a focused and rapid response and a significantly increased likelihood of successful rescucitation and hence survival.
The disclosed system and method are a cardiac arrest alert system that can identify the onset of a Sudden Cardiac Arrest and that, via audio, visual and electronic alerts, can directly inform a rescuer of the need to get a defibrillator to the victim's location as rapidly as possible. In doing so, the system aids in reducing the victim's effective time to first shock defibrillation.
This device, by notifying bystanders, key companions or family, and also EMS, to the occurrence and location of a cardiac arrest, and hence the urgent need for immediate defibrillation of the SCA victim, will save more lives than the current methodology that relies primarily on random chance that there are witnesses to both observe the victim's collapse and also to recognize that the victim has been struck by a SCA event. The system and method ensure that an actionable alert occurs even if the SCA happens while the victim is sleeping—which is currently a scenario that almost guarantees the death of the victim—and in this manner alone it significantly increases the likelihood that an external defibrillator can be applied to the victim in time to resuscitate them. The system and method ensure that, even if the victim has a SCA event while alone and out of sight of anyone else, the relevant people are immediately notified of the emergency and of the victim's location and they are then able to take the appropriate actions.
In one embodiment, the invention can even be used in conjunction with a specifically paired portable AED which can then emit audio and visual alerts that its services are required by the SCA victim. Such audio and visual alerts by the AED can also help in ensuring that the AED is located as rapidly as possible so that it can be used on the SCA victim with the minimum of delay. In another embodiment, the system and method makes use of a subcutaneous sensor component which is paired with and linked to an external monitoring/receiver device that emits the audio and visual alerts in addition to alerting EMS with the physical location of the patient. In another embodiment, the system and method makes use of a skin mounted disposable patch sensor component that is paired with and linked to an external monitoring/receiver device that emits the audio and visual alerts in addition to alerting EMS with the location. In any of these embodiments the system is designed to perform periodic self checks with regards to the energy source power levels and the operational health and readiness of the system. The results of which are reported through the alert/alarm component 206.
The heart signal monitor component 202 may monitor's a patient's heart signals, such as an ECG, and feed the captured heart signal data to the arrhythmia detecting component 204 that detects whether there is a lethal arrhythmia within the heart signals. In some embodiments, the heart signal monitor component 202 may receive more than one ECG signal from the patient and the heart signal monitor component 202 may monitor and analyze and compare/contrast the at least more than one different ECG signals from the same patient and selects the most accurate or reliable ECG signal.
If a lethal arrhythmia is detected, the alert/alarm component 206 may generate an alert/alarm about the lethal arrhythmia (to various people, systems, etc.) so that defibrillation may be applied to the patient. The alert/alarm component 206 may generate, or cause to be generated, an audio alarm, a visual alarm, a vibration alarm or an electronic or data alarm.
In one embodiment the receiver function may be combined into the same hardware as the sensor function. In another embodiment, the two functions are found in separate pieces of hardware. In some embodiments the patient has multiple sensor function devices placed in different locations about their body, which can include skin surface as well as subcutaneous and implanted locations. This ensures that the system has the maximum opportunity for eliminating noise and motion artifacts for the ECG signals, as well as the ability to compare the analyzed ECG signals to other bioinformatic sensor signals such as physical pulse readings and impedance readings in order to double check the algorithmic conclusions.
While the foregoing has been with reference to a particular embodiment of the invention, it will be appreciated by those skilled in the art that changes in this embodiment may be made without departing from the principles and spirit of the disclosure, the scope of which is defined by the appended claims.